Healthcare provider profile · identity verified

David Blinn

Internal Medicine · BELLEVUE, PA · NPI 1124091871

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	638	114
Lisinopril	Lisinopril	488	81
Omeprazole	Omeprazole	386	63
Amlodipine Besylate	Amlodipine Besylate	271	52
Gabapentin	Gabapentin	263	88
Levothyroxine Sodium	Levothyroxine Sodium	256	45
Metformin Hcl	Metformin Hcl	214	46
Tamsulosin Hcl	Tamsulosin Hcl	210	38
Pantoprazole Sodium	Pantoprazole Sodium	194	47
Metoprolol Tartrate	Metoprolol Tartrate	168	25
Trazodone Hcl	Trazodone Hcl	168	42
Furosemide	Furosemide	155	28
Simvastatin	Simvastatin	136	18
Hydrochlorothiazide	Hydrochlorothiazide	134	23
Meloxicam	Meloxicam	133	23
Eliquis	Apixaban	125	26
Finasteride	Finasteride	118	20
Losartan Potassium	Losartan Potassium	117	30
Sertraline Hcl	Sertraline Hcl	111	21
Albuterol Sulfate Hfa	Albuterol Sulfate	110	52
Glipizide Er	Glipizide	109	18
Oxybutynin Chloride Er	Oxybutynin Chloride	103	17
Quetiapine Fumarate	Quetiapine Fumarate	93	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	22
Potassium Chloride	Potassium Chloride	91	19
Metoprolol Succinate	Metoprolol Succinate	84	20
Risperidone	Risperidone	81	12
Fluticasone Propionate	Fluticasone Propionate	80	24
Olanzapine	Olanzapine	77	14
Fluoxetine Hcl	Fluoxetine Hcl	75	12
Mirtazapine	Mirtazapine	73	19
Clopidogrel	Clopidogrel Bisulfate	71	suppressed
Tramadol Hcl	Tramadol Hcl	70	19
Famotidine	Famotidine	68	19
Citalopram Hbr	Citalopram Hydrobromide	67	14
Xarelto	Rivaroxaban	67	suppressed
Alprazolam	Alprazolam	65	12
Buspirone Hcl	Buspirone Hcl	65	25
Duloxetine Hcl	Duloxetine Hcl	59	22
Ibuprofen	Ibuprofen	58	26
Montelukast Sodium	Montelukast Sodium	56	suppressed
Aripiprazole	Aripiprazole	55	13
Naproxen	Naproxen	54	suppressed
Donepezil Hcl	Donepezil Hcl	53	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	16
Pravastatin Sodium	Pravastatin Sodium	53	suppressed
Lorazepam	Lorazepam	51	11
Atenolol	Atenolol	49	suppressed
Tradjenta	Linagliptin	47	suppressed
Hydralazine Hcl	Hydralazine Hcl	44	suppressed
Jardiance	Empagliflozin	43	suppressed
Topiramate	Topiramate	43	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	42	34
Oxycodone Hcl	Oxycodone Hcl	41	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Prazosin Hcl	Prazosin Hcl	39	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	24
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	19
Rybelsus	Semaglutide	38	suppressed
Spiriva Respimat	Tiotropium Bromide	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Lamotrigine	Lamotrigine	35	12
Metformin Hcl Er	Metformin Hcl	34	suppressed
Nystatin	Nystatin	34	14
Allopurinol	Allopurinol	32	suppressed
Loperamide	Loperamide Hcl	32	13
Azithromycin	Azithromycin	31	26
Methylprednisolone	Methylprednisolone	31	25
Nifedipine Er	Nifedipine	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Clonazepam	Clonazepam	28	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Perphenazine	Perphenazine	26	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	26	suppressed
Lithium Carbonate Er	Lithium Carbonate	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	11
Midodrine Hcl	Midodrine Hcl	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Clobetasol Propionate	Clobetasol Propionate	23	11
Glipizide	Glipizide	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Diazepam	Diazepam	22	suppressed
Benztropine Mesylate	Benztropine Mesylate	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Gemfibrozil	Gemfibrozil	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Oxcarbazepine	Oxcarbazepine	20	suppressed
Temazepam	Temazepam	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Carbamazepine Er	Carbamazepine	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	17	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Carvedilol	Carvedilol	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Prednisone	Prednisone	16	14
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Bupropion Hcl	Bupropion Hcl	15	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	12
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Fluconazole	Fluconazole	15	11
Anastrozole	Anastrozole	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Colchicine	Colchicine	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Ozempic	Semaglutide	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Verapamil Sr	Verapamil Hcl	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Linzess	Linaclotide	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error